NCT03037606View on ClinicalTrials.gov

Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

December 1, 2018

Study Completion Date

December 11, 2018

Conditions
Gastroesophageal Reflux Disease
Interventions
DRUG

Rabelis DDR 50 mg Capsules

Rabelis DDR 50 mg Capsules once daily for seven days.

DRUG

Pariet 20 mg Enteric Coated Tablets

Pariet 20 mg Enteric Coated Tablets once daily for seven days.

Trial Locations (1)

35100

Ege University Facult of Medicine Gastroenterology Department, Izmir

All Listed Sponsors
lead

Neutec Ar-Ge San ve Tic A.Ş

INDUSTRY

NCT03037606 - Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets | Biotech Hunter | Biotech Hunter